Market Cap Chart

View Market Cap for RHHVF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Market Cap Chart
Start Trial

Historical Market Cap Data

View and export this data back to 2026. Start Trial.
Date Value
August 24, 2026 367.38B
August 21, 2026 373.36B
August 20, 2026 365.33B
August 19, 2026 370.03B
August 18, 2026 353.79B
August 17, 2026 347.44B
August 14, 2026 345.46B
August 13, 2026 361.73B
August 12, 2026 362.51B
August 11, 2026 354.56B
August 10, 2026 362.53B
August 07, 2026 367.07B
August 06, 2026 363.23B
August 05, 2026 359.34B
August 04, 2026 355.20B
August 03, 2026 348.89B
July 31, 2026 350.11B
July 30, 2026 350.58B
July 29, 2026 352.33B
July 28, 2026 358.94B
July 27, 2026 350.58B
July 24, 2026 342.23B
July 23, 2026 341.06B
July 22, 2026 324.27B
July 21, 2026 336.48B
Date Value
July 20, 2026 328.47B
July 17, 2026 322.69B
July 16, 2026 325.90B
July 15, 2026 334.93B
July 14, 2026 330.50B
July 13, 2026 320.54B
July 10, 2026 334.26B
July 09, 2026 329.73B
July 08, 2026 317.61B
July 07, 2026 330.66B
July 06, 2026 323.29B
July 02, 2026 327.31B
July 01, 2026 331.93B
June 30, 2026 330.02B
June 29, 2026 331.07B
June 26, 2026 327.87B
June 25, 2026 329.74B
June 24, 2026 327.67B
June 23, 2026 326.18B
June 22, 2026 306.32B
June 18, 2026 311.46B
June 17, 2026 321.03B
June 16, 2026 321.57B
June 15, 2026 322.23B
June 12, 2026 333.01B

Market Capitalization Definition

Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.

Read full definition.

Market Cap Range, Past 5 Years

View Market Cap Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Market Cap Benchmarks

View Market Cap Benchmarks
Start Trial
Novartis AG 292.89B
Addex Therapeutics Ltd. 3.729M
Oculis Holding AG 799.12M
Sandoz Group AG 39.56B
Galderma Group AG 49.54B

Market Cap Related Metrics

PE Ratio 42.61
PS Ratio 4.832
Price 461.10
Earnings Yield 2.35%
Operating PE Ratio 15.76